<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02092376</url>
  </required_header>
  <id_info>
    <org_study_id>LOAD</org_study_id>
    <secondary_id>2013-003546-16</secondary_id>
    <nct_id>NCT02092376</nct_id>
  </id_info>
  <brief_title>The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery</brief_title>
  <acronym>LOAD</acronym>
  <official_title>The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery: a Randomized Controlled, Double-blinded Clinical Supplementation Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maria Luger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to increase vitamin D concentrations or to keep it on high level,
      respectively, by supplementing with vitamin D3 in a different dose regime, and to improve the
      overall health status in bariatric patients. In this project, the vitamin D status, the
      parameters of inflammation, bone turnover, insulin resistance, liver and depression score of
      bariatric patients are expected to improve, due to supplementation of a loading dose compared
      to the standard therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>25-hydroxy vitamin D levels</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>25-hydroxy vitamin D levels after 24 weeks measured in intervention and placebo group, adjusting for the baseline value as covariate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of sufficient vitamin D</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Number of patients reaching 25-hydroxyvitamin D levels above 75 nmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of vitamin D deficiency</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Prevalence of vitamin D deficiency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Co-morbidities</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Prevalence of Co-morbidities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prescribed medication</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Change in prescribed medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight, body composition</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Change in body weight and body composition by bioelectrical impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Change of vital signs (blood pressure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Change in laboratory parameters compared to baseline: vitamin D status, bone turnover markers, calcium homeostasis, parathyroid hormone, inflammation, insulin resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptoms</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Prevalence of depression symptoms assessed by Beck Depression Inventory Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density and body fat content</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Assessment of bone mineral density and total body fat content by DEXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver condition</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Measurement of liver stiffness and fat content by FibroScan and CAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary assessment</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Dietary assessment will be documented with a 5-day food record to calculate vitamin D intake and the Mediterranean Score (questionnaire with calculated score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut microbiota composition</measure>
    <time_frame>24 weeks postoperatively</time_frame>
    <description>Association between vitamin D, gut microbiota and surgery-induced weight loss, by collecting stool samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D in adipose and liver tissue</measure>
    <time_frame>during surgery</time_frame>
    <description>For instance, for the purposes of describing adipose depot vitamin D concentrations and expression of enzymes in subcutaneous, visceral adipose and liver tissue samples will be collected during the omega loop gastric bypass surgery. Furthermore, the liver tissue samples should be used in addition for a histological examination as extended diagnostics (NAFLD/ NASH).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The loading dose of 300 000 IU is divided into three doses (100 000 IU) and will be given over the first months. All patients in the intervention group will receive the first loading dose of 100 000 IU at day of discharge. The second (2 weeks) and third (4 weeks postoperative) administration will be given based on the 25-hydroxy vitamin D concentration. After the last respectively third loading dose a maintenance dose of 3420 IU per day should maintain the high 25-hydroxy vitamin D concentration. It should be administered for up to 46 weeks (until follow-up visit)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo loading dose (oil) is divided into three administrations and will be given over the first months. All patients in the placebo group will receive the first placebo loading dose at day of discharge. After the last placebo loading dose a maintenance dose of 3420 IU per day should maintain the 25-hydroxy vitamin D concentration. It should be administered for up to 46 weeks (until follow-up).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned omega loop bypass surgery

          -  25-hydroxy vitamin D &lt; 75 nmol/l

          -  BMI &gt;40 or ≥35 kg/m2 with co-morbidities e.g. diabetes mellitus, hypertension

          -  Body weight &lt;140 kg (due to limitation of DEXA measurement)

          -  Capability to consent

        Exclusion Criteria:

          -  Another planned form of bariatric surgery

          -  Hypercalcemia (calcium &gt;2.63 mmol/l) or hypocalcemia (&lt;1.75 mmol/l)

          -  Renal insufficiency (creatinine &gt;133 μmol/l or GFR &lt;50 ml/min)

          -  Primary hyperparathyroidism

          -  Malignancy

          -  Infection e.g. human immunodeficiency virus

          -  Medical conditions requiring daily calcium supplements or antacid use

          -  Known hypersensitivity to cholecalciferol

          -  No capability to consent

          -  Imprisoned persons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard Ludvik, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Endocrinology &amp; Metabolism, Department of Internal Medicine III, Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2014</study_first_submitted>
  <study_first_submitted_qc>March 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2014</study_first_posted>
  <last_update_submitted>July 13, 2016</last_update_submitted>
  <last_update_submitted_qc>July 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Maria Luger</investigator_full_name>
    <investigator_title>Maria Luger, MSc</investigator_title>
  </responsible_party>
  <keyword>Bariatric surgery</keyword>
  <keyword>vitamin D</keyword>
  <keyword>supplementation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

